首页> 美国卫生研究院文献>International Journal of Veterinary Science and Medicine >Effects of Yunnan Baiyao on blood coagulation parameters in beagles measured using kaolin activated thromboelastography and more traditional methods
【2h】

Effects of Yunnan Baiyao on blood coagulation parameters in beagles measured using kaolin activated thromboelastography and more traditional methods

机译:云南白药对高岭土激活血栓弹力图及其他传统方法测量比格犬血凝参数的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Yunnan Baiyao is anecdotally widely used in veterinary medicine for its pro-coagulation properties. There are no studies determining its effect on clotting tests. The purpose of this study was to determine the effect of oral Yunnan Baiyao (YB) on hemostasis by measuring coagulation via kaolin activated citrated whole blood thromboelastography (TEG), prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, and d-dimers. The study was a prospective, randomized controlled crossover trial. Eight healthy University of Calgary owned beagles were treated orally with either Yunnan Baiyao or placebo every 12 h for 5 treatments. Blood was collected immediately before treatment, 2 h after the last treatment, and 24 h after the last treatment. TEG analysis was run 30 ± 5 min after blood collection. All other coagulation analyses were sent to a reference laboratory for further analysis. No treatment adverse effects were observed. Oral YB increased R-time significantly within the YB group, but the increase was still within canine reference ranges. No other changes were observed. Oral YB at the dosage and frequency administered in this study did not produce any significant improvement in hemostatic parameters. There is a need for further research and scientific evidence for YB use and dosage.
机译:云南白药具有促凝血作用,因此在兽医学中被广泛使用。没有研究确定其对凝血试验的影响。这项研究的目的是通过测量高岭土活化的柠檬酸化全血凝血弹性成像(TEG),凝血酶原时间(PT),活化的部分凝血活酶时间(aPTT),纤维蛋白原和d-二聚体。该研究是一项前瞻性,随机对照试验。每12小时口服一次云南白药或安慰剂对八只健康的卡尔加里大学拥有的小猎犬进行5次治疗。在治疗前,最后治疗后2小时和最后治疗后24小时收集血液。采血后30±5分钟进行TEG分析。所有其他凝血分析均送至参考实验室进行进一步分析。没有观察到治疗不良反应。在YB组中,口服YB显着增加了R时间,但该增加仍在犬参考范围内。没有观察到其他变化。在这项研究中,口服YB的剂量和频率并未使止血参数产生任何显着改善。对于YB的使用和剂量,需要进一步的研究和科学证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号